Latest filing published 11 Jan 2023 for TC BioPharm (Holdings) plc, €339k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Edward Randall: trading record in brief
This profile gathers the share dealings of Mark Edward Randall in TC BioPharm (Holdings) plc. Altogether 2 filings, all relating to 30 November 2022.
The open-market record is one-sided, with 2 purchases worth €678k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2023: 2 purchases and no sales on the market.
The newest entry dates from 11 January 2023: an open-market purchase of €339k, in TC BioPharm (Holdings) plc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Edward Randall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 70,000 shares@ US$5.00100.0% of flowOrdinary Shares [ADS]SEC:0001920179-23-000005:0Canonical exit: 28 Feb 2023 (T+90)
1 of 1 declaration